CTI Biopharma (Formerly Cell Therapeutics)

CTI Biopharma (Formerly Cell Therapeutics)

CTI BioPharma | Seeking to Bring New Options to Patients with Blood Cancers.

Launch date
Employees
Market cap
CAD1.6b
Enterprise valuation
CAD1.6b (Public information from Jul 2023)
Seattle Washington (HQ)
Authorizing premium user...